Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dPCR validation through planned imatinib discontinuation in PCR-negative CML
NL-OMON37795Phase 4Active, not recruiting
- Sponsor
- University of Milano-Bicocca
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib in chronic myelogenous leukemia (CML), sponsored by University of Milano-Bicocca. Started Oct 2012; status: active, not recruiting.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NL-OMON37795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37795.